Canaccord Genuity analyst Maria Ripps raised the price target on Hims and Hers (NYSE: HIMS) to $24.00 (from $20.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Citi Downgrades Hims and Hers (HIMS) to NeutralMay 22, 2024 2:35 AM Form 4 Hims & Hers Health, Inc. For: May 20 Filed by: Boughton SoleilMay 21, 2024 4:41 PM Form 4 Hims & Hers Health, Inc. For: May 17 Filed by: Becklund IreneMay 20, 2024 4:44 PM Form 144 Hims & Hers Health, Inc. Filed by: Boughton SoleilMay 20, 2024 4:20 PM Hims & Hers Health, Inc. (HIMS) call put ratio 3.4 calls to 1 put as share price up 27%May 20, 2024 3:32 PM Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)May 20, 2024 3:08 PM Citi Reiterates Buy Rating on Hims and Hers (HIMS)May 20, 2024 11:49 AM Hims & Hers Health (HIMS) Announces Access to GLP-1 InjectionsMay 20, 2024 9:01 AM Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto CustomersMay 20, 2024 9:00 AM Midday movers: Nvidia, Micron and Wix rise; Li Auto fallsMay 20, 2024 7:41 AM